Cai Z, Lin S, Fan L-W, Pang Y, Rhodes P G
Department of Pediatrics, Division of Newborn Medicine, University of Mississippi Medical Center, Jackson, 39216-4505, USA.
Neuroscience. 2006;137(2):425-35. doi: 10.1016/j.neuroscience.2005.09.023. Epub 2005 Nov 14.
The role of minocycline in preventing white matter injury, in particular the injury to developing oligodendrocytes was examined in a neonatal rat model of hypoxia-ischemia. Hypoxia-ischemia was achieved through bilateral carotid artery occlusion followed by exposure to hypoxia (8% oxygen) for 15 min in postnatal day 4 Sprague-Dawley rats. A sham operation was performed in control rats. Minocycline (45 mg/kg) or normal phosphate-buffered saline was administered intraperitoneally 12 h before and immediately after bilateral carotid artery occlusion+hypoxia and then every 24 h for 3 days. Nissl staining revealed pyknotic cells in the white matter area of the rat brain 1 and 5 days after hypoxia-ischemia. Hypoxia-ischemia insult also resulted in apoptotic oligodendrocyte cell death, loss of O4+ and O1+ oligodendrocyte immunoreactivity, and hypomyelination as indicated by decreased myelin basic protein immunostaining and by loss of mature oligodendrocytes in the rat brain. Minocycline significantly attenuated hypoxia-ischemia-induced brain injury. The protective effect of minocycline was associated with suppression of hypoxia-ischemia-induced microglial activation as indicated by the decreased number of activated microglia, which were also interleukin-1beta and inducible nitric oxide synthase expressing cells. The protective effect of minocycline was also linked with reduction in hypoxia-ischemia-induced oxidative and nitrosative stress as indicated by 4-hydroxynonenal and nitrotyrosine positive oligodendrocytes, respectively. The reduction in hypoxia-ischemia-induced oxidative stress was also evidenced by the decreases in the content of 8-isoprostane in the minocycline-treated hypoxia-ischemia rat brain as compared with that in the vehicle-treated hypoxia-ischemia rat brain. The overall results suggest that reduction in microglial activation may protect developing oligodendrocytes in the neonatal brain from hypoxia-ischemia injury.
在新生大鼠缺氧缺血模型中,研究了米诺环素在预防白质损伤,特别是对发育中的少突胶质细胞损伤方面的作用。通过双侧颈动脉闭塞,然后在出生后第4天的斯普拉格-道利大鼠中暴露于低氧(8%氧气)15分钟来实现缺氧缺血。对对照大鼠进行假手术。在双侧颈动脉闭塞+缺氧前12小时和后立即腹腔注射米诺环素(45mg/kg)或正常磷酸盐缓冲盐水,然后每24小时注射一次,持续3天。尼氏染色显示缺氧缺血后1天和5天大鼠脑白质区域有固缩细胞。缺氧缺血损伤还导致凋亡性少突胶质细胞死亡、O4+和O1+少突胶质细胞免疫反应性丧失以及髓鞘碱性蛋白免疫染色减少和大鼠脑中成熟少突胶质细胞丢失所表明的髓鞘形成减少。米诺环素显著减轻了缺氧缺血诱导的脑损伤。米诺环素的保护作用与缺氧缺血诱导的小胶质细胞活化的抑制有关,这表现为活化小胶质细胞数量减少,这些小胶质细胞也是表达白细胞介素-1β和诱导型一氧化氮合酶的细胞。米诺环素的保护作用还与缺氧缺血诱导的氧化应激和亚硝化应激的降低有关,分别表现为4-羟基壬烯醛和硝基酪氨酸阳性的少突胶质细胞。与载体处理的缺氧缺血大鼠脑相比,米诺环素处理的缺氧缺血大鼠脑中8-异前列腺素含量的降低也证明了缺氧缺血诱导的氧化应激的降低。总体结果表明,小胶质细胞活化的减少可能保护新生脑发育中的少突胶质细胞免受缺氧缺血损伤。